Welcome to Nino’s News. Our guest blogger, Anthony “Nino” Sireci, M.D. is vice president, clinical biomarker and diagnostics development, Loxo Oncology at Lilly. Dr. Sireci is a board-certified Clinical Pathologist and a practicing molecular pathologist. Prior to joining Loxo, he was an Assistant Professor of Pathology and Cell Biology at Columbia University and a medical director in the Laboratory of Personalized Genomic Medicine at Columbia Medical Center.
Nino's News
You might also like: Why lung cancer biomarker testing matters for RET-positive patients.
